Stocks to Watch: Infosys, Aurobindo Pharma, Swan Defence, Arvind SmartSpaces, Prostarm Info, CleanMax, ICRA, Dredging Corporation in Focus on April 8

Stock Market Update: Key Developments and Announcements

The stock market is witnessing a flurry of activity, with several companies announcing significant investments, deals, quarterly earnings, acquisitions, and order wins. Here's a rundown of the key developments and announcements that will be in focus in today's trade.

Quarterly Business Update

Ashiana Housing has reported a significant increase in its quarterly business performance. In its Q4 (Year-over-Year) results, the company saw a 32% rise in area booked to 11.19 lakh sqft, compared to 8.48 lakh sqft in the same period last year. The value of area sold jumped 124.4% to Rs 1,289.7 crore, up from Rs 574.7 crore in the same period last year. The company also reported a 12% increase in the number of units booked to 665 units, compared to 597 units in the same period last year.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Stocks to Watch

Infosys

Infosys has announced a strategic collaboration with Harness to accelerate agentic AI-led software delivery transformation for enterprises globally.

GAIL (India)

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

GAIL (India) has entered into a long-term charter party agreement with Alpha Gas, a leading Greek shipping major, for the LNG carrier Energy Fidelity. The charter party agreement was executed between GAIL and Pantheon Maritime Services, a Singapore-based affiliate of Alpha Gas.

Recent Announcements

Aurobindo Pharma

Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Dapagliflozin and Metformin hydrochloride extended-release tablets in strengths of 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg. These are bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xigduo XR tablets of AstraZeneca.

These products will be manufactured at Unit IV of the company's subsidiary, APL Healthcare, and will be launched immediately. Dapagliflozin and Metformin hydrochloride extended-release tablets are used as an adjunct to diet and exercise to improve glycaemic control in adults with Type 2 diabetes mellitus.

Biocon

Biocon has announced the commercial launch of Bosaya (denosumab-kyqq) and Aukelso (denosumab-kyqq) in the United States. Both products were previously approved and granted interchangeable designation by the US Food and Drug Administration in September 2025.

Swan Defence and Heavy Industries

Swan Defence and Heavy Industries has received a new order worth Rs 1,500–3,000 crore from Energy ONE for the construction of four 92,500 DWT dual-fuel ammonia bulk carriers. These will be the first ammonia dual-fuel ships built in India. The first vessel is expected to be delivered in October 2029.

Recent Orders and Awards

Prostarm Info Systems

Prostarm Info Systems has received a Letter of Award (LoA) as a subcontractor from Solarium Green Energy for executing complete engineering, procurement, and construction (EPC) works worth Rs 165 crore for a 50 MWac solar PV power project, excluding three years of operation and maintenance (O&M) services in Maharashtra.

Additionally, the company has signed a Memorandum of Understanding (MoU) with Shenzhen Topband Co to explore a potential strategic alliance for exclusive cooperation in battery energy storage systems (BESS).

Arvind SmartSpaces

Arvind SmartSpaces has signed a residential high-rise project in Goregaon (West), Mumbai. The project has a topline potential of around Rs 2,400 crore, with a total saleable carpet area of approximately 0.67 million sq ft.

Recent Developments in the Renewable Energy Sector

Clean Max Enviro Energy Solutions

Clean Max Enviro Energy Solutions has announced the commissioning of its 185 MW hybrid renewable energy project at Kalavad, which is expected to add over Rs 165 crore annually to its revenue base in FY27 once stabilised. Comprising integrated solar and wind capacity, the project has been developed over approximately 12 months and will supply green energy to 17 corporate customers.

Recent Developments in the Industrial Sector

SRF

The Competition Commission of India has approved a primary capital investment of around Rs 2,750 crore in the company's subsidiary, Aditya Birla Housing Finance, from Indriya, one of the entities of Advent International.

Recent Developments in the Financial Sector

Muthoot Finance

The Board of Directors of Muthoot Finance will meet on April 10 to consider an interim dividend for the financial year 2025–26.

Recent Developments in the Real Estate Sector

Aditya Birla Real Estate

Aditya Birla Real Estate's subsidiary, Birla Estates, has achieved bookings exceeding Rs 1,600 crore for its luxury project, Birla Arika Phase 2 in Gurugram. Nearly 97% of the residences (152 out of 156 units) were sold within a month of launch, underlining strong buyer confidence in the brand's luxury developments.

Bulk Deals

ICRA

Nippon India Mutual Fund has purchased an additional 1.44 lakh shares (1.5% stake) in ICRA for Rs 73.56 crore through two transactions, at a price of Rs 5,075 per share. Nippon Life India Trustee, through its Nippon India Small Cap Fund, already held a 6.88% stake in the rating agency as of March 2026.

Cello World

Goldman Sachs Funds, through its Goldman Sachs India Equity Portfolio, sold 13.82 lakh shares (0.62% stake) in Cello World at Rs 401 per share, valued at Rs 55.45 crore. The global fund house held a 1.34% stake in the company as of December 2025.

Mahanagar Gas

Eastspring Investments India Equity Open Fund, part of Prudential plc, offloaded 7.25 lakh shares (0.73% stake) for Rs 69.39 crore at Rs 957.01 per share. Eastspring Investments held a 1.14% stake in Mahanagar Gas prior to the transaction.

Sai Parenterals

Non-institutional investor Bhaskara Rao Bollineni has purchased an additional 5.12 lakh shares (1.15% stake) in the company at Rs 409.25 per share, valued at Rs 20.96 crore. Bhaskara Rao already held a 2.9% stake in the company as of March 2026.